HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig.

Abstract
Anti-epileptic drugs (AEDs) are increasingly used for the treatment of neuropathic pain. Oxcarbazepine is a recently introduced AED that is effective in treating epilepsy and has an improved side-effect profile compared to existing therapies. Here we have examined the effect of oxcarbazepine and other AEDs in a model of neuropathic pain in the rat and guinea-pig. Oxcarbazepine and carbamazepine (3-100 mg x kg(-1)) did not affect mechanical hyperalgesia or tactile allodynia induced by partial sciatic nerve ligation in the rat following oral administration. However, in the same model in the guinea-pig, both drugs produced up to 90% reversal of mechanical hyperalgesia with respective D(50) values of 10.7 and 0.8 mg x kg(-1). The active human metabolite of oxcarbazepine, monohydroxy derivative, was similarly active against mechanical hyperalgesia in the guinea-pig but not the rat. Lamotrigine (3-100 mg x kg(-1), p.o.) was effective against mechanical hyperlagesia in both species although it showed greater efficacy and potency in the guinea-pig (D(50) 4.7 mg x kg(-1)) compared to the rat (D(50) 27 mg kg(-1)). Lamotrigine produced slight inhibition of tactile allodynia in the rat only at the highest dose tested of 100 mg x kg(-1). Gabapentin was poorly active against mechanical hyperalgesia in both the rat and guinea-pig following a single oral administration (100 mg x kg(-1)), although upon repeated administration it produced up to 70 and 90% reversal in rat and guinea-pig, respectively. Gabapentin did however produce significant dose-related reversal of tactile allodynia in the rat following a single administration. These data show that oxcarbazepine and other AEDs are effective anti-hyperalgesic or anti-allodynic agents in an animal model of neuropathic pain, and provide further support for their use in the treatment of neuropathic pain in the clinic.
AuthorsAlyson Fox, Clive Gentry, Sadhana Patel, Adam Kesingland, Stuart Bevan
JournalPain (Pain) Vol. 105 Issue 1-2 Pg. 355-62 (Sep 2003) ISSN: 0304-3959 [Print] United States
PMID14499454 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Acetates
  • Amines
  • Anticonvulsants
  • Cyclohexanecarboxylic Acids
  • Triazines
  • Carbamazepine
  • gamma-Aminobutyric Acid
  • Gabapentin
  • Lamotrigine
  • Oxcarbazepine
Topics
  • Acetates (pharmacology)
  • Amines
  • Animals
  • Anticonvulsants (pharmacology)
  • Carbamazepine (analogs & derivatives, pharmacology)
  • Cyclohexanecarboxylic Acids
  • Gabapentin
  • Guinea Pigs
  • Hyperalgesia (etiology, physiopathology)
  • Lamotrigine
  • Male
  • Neuralgia (etiology, physiopathology)
  • Oxcarbazepine
  • Pain Threshold
  • Pressure
  • Rats
  • Rats, Wistar
  • Sciatic Nerve (injuries)
  • Touch
  • Triazines (pharmacology)
  • Wounds and Injuries (complications)
  • gamma-Aminobutyric Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: